Shares in Marmite maker Unilever are sharply lower after it made an audacious swoop for GlaxoSmithKline's consumer healthcare arm.
The food giant told investors that the Glaxo unit is a “strong strategic fit” as part of it pursuit of sales categories with higher rates of sustainable growth.
